Structured Educational Program vs Standard Care in Pre-surgical Critical Limb Ischemia Patients
Impact of a Structured Multimodal Educational Program on Clinical Outcomes and Quality of Life in Patients With Critical Limb Ischemia: A Randomized Controlled Trial.
1 other identifier
interventional
184
1 country
1
Brief Summary
Critical limb ischemia (CLI) is a severe condition where poor blood flow to the legs causes pain, non-healing wounds, and may require amputation. It affects 10% of people over 40, rising to 20% in those over 70. Within the first year after diagnosis, 30% of patients need amputation and 25% die. Current treatments include medications, surgery to restore blood flow, or amputation, but results remain poor. Research shows that lifestyle changes like quitting smoking and regular exercise can significantly improve outcomes, yet most CLI patients struggle to make these changes and lack knowledge about their condition. This study tests whether a structured educational program called the "Critical Limb Ischemia School" can help patients. The program teaches patients about their condition, symptom management, lifestyle modifications, and when to seek medical help. The investigators will compare patients receiving this education to those getting standard care. The study will evaluate several important health outcomes during a 12-month period to determine if the educational program makes a meaningful difference in patients' lives. The investigators will assess how the intervention affects patients' overall well-being, their ability to manage symptoms and daily activities, and whether it helps prevent serious complications that could lead to disability. If successful, this program could provide a cost-effective way to help CLI patients manage their condition and potentially avoid serious complications like amputation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 17, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedMarch 10, 2026
March 1, 2026
1.2 years
September 17, 2025
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Frequency of CLI-related hospitalizations
Total number of hospitalizations related to critical limb ischemia or its complications (such as limb infections, need for revascularization, amputation) per patient during the follow-up period.
12 months from enrollment
SF-12 Quality of Life Score
12-Item Short Form Health Survey (SF-12) Physical Component Summary (PCS): 0-100 Mental Component Summary (MCS): 0-100 Higher scores indicate better quality of life and better health status.
Baseline, 6 months, and 12 months from enrollment
Secondary Outcomes (5)
Visual Analog Scale (VAS) Pain Score
Baseline, 6 months, and 12 months from enrollment
Proportion of disability cases
12 months from enrollment
Smoking cessation rate
12 months from enrollment
Pain-free walking distance
Baseline, 12 months from enrollment
Quality-Adjusted Life Years (QALY)
12 months from enrollment
Study Arms (2)
Educational Program + Standard Medical Care
EXPERIMENTALParticipants receive a comprehensive 4-week multimodal educational program including interactive group sessions, digital platform access, printed materials, and medical hotline access in addition to standard medical care.
Standard Medical Care
OTHERParticipants receive standard medical care for critical limb ischemia including routine vascular surgery consultation, standard medical management, and usual wound care instructions without any structured educational intervention.
Interventions
Routine clinical management for critical limb ischemia according to current standard of care guidelines. Includes vascular surgery consultation and scheduled follow-up appointments as clinically indicated. No structured educational materials, formal patient education sessions, or additional follow-up contacts beyond routine clinical care are provided. Patients receive standard verbal and written instructions during consultation and have access to the same medical and surgical treatments as the intervention group when clinically warranted.
A comprehensive 4 weeks educational program combining face-to-face and digital learning modalities. Components include: interactive group sessions twice a week led by vascular specialists covering the pathophysiology of disease, risk factor modification, and treatment options; digital platform access with multimedia educational materials, printed educational materials for home reference; peer support group participation; medical hotline access for patient-initiated consultations and urgent questions; smoking cessation counseling; supervised exercise program recommendations; wound care training. The program emphasizes patient self-management skills, early recognition of complications, and adherence to medical therapy alongside standard clinical care.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Confirmed diagnosis of chronic critical limb ischemia (CLI)
- Rutherford category 2-5
- Ability to understand study procedures and provide signed and dated written informed consent
- Fluency in Russian language
- Access to telephone and internet
You may not qualify if:
- Severe cognitive impairment
- Participation in another clinical trial that might interfere with study outcomes
- Planned major amputation within 3 months
- Diabet 1 and 2 type
- Inability to attend scheduled educational sessions
- Severe visual or hearing impairments that would interfere with participation in educational sessions
- Patients who declined to participate after being informed about the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tulip Medicinelead
Study Sites (1)
NCJSC "Astana Medical University"
Astana, Kazakhstan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of department
Study Record Dates
First Submitted
September 17, 2025
First Posted
October 1, 2025
Study Start
September 30, 2024
Primary Completion
December 26, 2025
Study Completion
December 26, 2025
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share